Cargando…
Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has necessitated the global development of countermeasures since its outbreak. However, current therapeutics and vaccines to stop the pandemic are insufficient and this is mainly...
Autores principales: | Takazawa, Shunta, Kotaki, Tomohiro, Nakamura, Satsuki, Utsubo, Chie, Kameoka, Masanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374963/ https://www.ncbi.nlm.nih.gov/pubmed/37473963 http://dx.doi.org/10.1016/j.virusres.2023.199176 |
Ejemplares similares
-
Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon
por: Nakamura, Akina, et al.
Publicado: (2022) -
A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation
por: Kotaki, Tomohiro, et al.
Publicado: (2021) -
CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures
por: Ophinni, Youdiil, et al.
Publicado: (2018) -
Broad-spectrum antiviral agents: secreted phospholipase A(2) targets viral envelope lipid bilayers derived from the endoplasmic reticulum membrane
por: Chen, Ming, et al.
Publicado: (2017) -
Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies
por: Nguyen, Hai Trong, et al.
Publicado: (2021)